Maine Medicine Weekly Update - Maine Medicine Weekly Update: 12/24/2021  (Plain Text Version)

Return to Graphical Version

 

In this issue:
HAPPY HOLIDAYS FROM THE MMA
•  Enjoy The Holidays, Our Weekly Newsletter & Thank You For All You Do
COVID-19 CORNER
•  FDA Updates: Pfizer & Merck Oral Antivirals Authorized; Omicron & Monoclonal Antibodies
•  Maine CDC Updates & Guidance
•  Reminder: Everyone Ages 16 and Older Can Get a Booster Shot
•  US CDC Reduces Time for Health Care Workers to Isolate & Updates School Guidelines
•  English Study: Booster Shots Protect Against Omicron for About 10 Weeks
•  Patients Vaccinated for COVID-19 Have Shorter Hospital Stays Than Unvaccinated Patients
•  JAMA Internal Medicine - Illness Severity With SARS-CoV-2 Infection, Delta vs Beta Variant
•  US Supreme Court to Take Up Federal COVID-19 Vaccine Rules
WHAT'S NOT COVID RELATED
•  CDC: Physicians Should Discuss Meds to Reduce HIV Risk
•  HHS: $48 Million Available to Increase the Public Health Workforce in Rural and Tribal Communities
•  MaineCare: Payment Cycle Reminder: Christmas and New Year's Day Holidays
IN THE NEWS
•  Medicine in the Media
•  Walgreens Pharmacy Hours Change: Call Ahead Before Picking Up Your Medication
MAINE MEDICAL ASSOCIATION JOB OPPORTUNITY
•  Maine Medical Education Trust (MMET) CME Program Coordinator
HEALTH COVERAGE
•  Open Enrollment For 2022 Individual Health Plans
UPCOMING EVENTS
•  Upcoming Specialty Society Meetings
•  Governorís Opioid Response Seminar Webinar Series Continues (Jan 7)
HEALTHCARE EMPLOYMENT OPPORTUNITIES
•  Psychiatric Nurse Practitioner (PNP) - Greater Portland Health
•  Transformational OB/GYN or Maternal Fetal Medicine Physician leader

 

English Study: Booster Shots Protect Against Omicron for About 10 Weeks

As US health officials announced the Omicron wave (which has not peaked) has officially surpassed the height of the Delta surge, a new study from the UK Health Security Agency shows, “Booster protection against symptomatic illness caused by the Omicron variant dropped by up to 25% within 10 weeks, new real-world data found — though it's not yet clear whether everyone may need further doses in 2022.”

As US health officials announced the Omicron wave (which has not peaked) has officially surpassed the height of the Delta surge, a new study from the UK Health Security Agency shows, “Booster protection against symptomatic illness caused by the Omicron variant dropped by up to 25% within 10 weeks, new real-world data found — though it's not yet clear whether everyone may need further doses in 2022.”

Booster protection against symptomatic COVID-19 caused by Omicron lasts about 10 weeks, data shows. It may mean fourth doses in 2022 — depending on whether protection holds against severe COVID-19. Immunocompromised Americans can already get an extra shot.

According to the UK Health Security Agency, “Booster protection against symptomatic illness caused by the Omicron variant dropped by up to 25% within 10 weeks, new real-world data found — though it's not yet clear whether everyone may need further doses in 2022.”

Business Insider: Booster Shots Protect Against Symptomatic Omicron Infection for About 10 Weeks, Study Finds — Which Could Mean More Doses For Some In 2022

UK Health Security Agency technical briefing: SARS-CoV-2 Variants Of Concern And Variants Under Investigation In England